Skip to content
  • Sunday, 26 July 2026
  • 2:54 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Gilead Sciences Finalizes $5 Billion Acquisition of Tubulis, Bolstering Oncology Pipeline with Advanced ADC Technology
Pharmaceutical R&D

Gilead Sciences Finalizes $5 Billion Acquisition of Tubulis, Bolstering Oncology Pipeline with Advanced ADC Technology

Teuku Ryan May 23, 2026 0

Gilead Sciences has officially completed its acquisition of Tubulis, a prominent German biotechnology firm specializing in the development of next-generation…

Read More
Pharmaceutical R&D

Gilead Sciences Pledges Over 400,000 Doses of AmBisome to Combat Visceral Leishmaniasis, Extending Vital Global Health Partnership

Teuku Ryan May 21, 2026 0

Gilead Sciences has announced a significant commitment to global health, pledging over 400,000 doses of its vital antifungal medication, AmBisome…

Read More
Laboratory Automation & Robotics

Sai Life Sciences’ Biotech Pitch Day 2026 Unveils Groundbreaking Innovations from Early-Stage Biotechs, Reinforcing Global Drug Discovery Ecosystem

Lana Keisha May 17, 2026 0

Sai Life Sciences, a leading global contract research, development, and manufacturing organization (CRDMO), recently convened its highly anticipated Biotech Pitch…

Read More
Laboratory Automation & Robotics

Sai Life Sciences’ Biotech Pitch Day 2026 Ignites Innovation with Promising Early-Stage Biotech Ventures

Lana Keisha May 10, 2026 0

Sai Life Sciences, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), recently convened its highly anticipated Biotech Pitch…

Read More
Pharmaceutical R&D

Gilead Sciences Reports Robust Q1 2026 Performance Driven by Strong HIV Portfolio and Promising PrEP Launches

Teuku Ryan May 9, 2026 0

Gilead Sciences has commenced 2026 with a demonstrably strong first quarter, reporting significant revenue growth primarily fueled by its leading…

Read More
Laboratory Automation & Robotics

Sai Life Sciences Hosts Landmark Biotech Pitch Day 2026, Spotlighting Innovative Early-Stage Therapies and Fostering Strategic Collaborations

Lana Keisha May 1, 2026 0

Sai Life Sciences, a leading global contract research, development, and manufacturing organization (CRDMO), recently convened its highly anticipated Biotech Pitch…

Read More
Biotech & Genetic Research

The Interconnected Landscape of PCR Technologies: Driving Precision and Discovery in Modern Life Sciences

Jia Lissa May 1, 2026 0

In the rapidly evolving landscape of life sciences, Polymerase Chain Reaction (PCR) stands as a foundational molecular biology technique, indispensable…

Read More
Laboratory Automation & Robotics

Sai Life Sciences’ Biotech Pitch Day 2026 Spotlights Pioneering Early-Stage Biotech Innovations Addressing Critical Unmet Medical Needs

Lana Keisha Apr 23, 2026 0

Sai Life Sciences recently convened its highly anticipated Biotech Pitch Day 2026 at its strategically located Boston-area site, gathering a…

Read More
Biotech & Genetic Research

Advancing Cancer Research and Life Sciences: Insights from AACR and North American Innovation Landscape

Jia Lissa Apr 18, 2026 0

The American Association for Cancer Research (AACR) Annual Meeting, held this year in San Diego, CA, USA, from April 17–22,…

Read More
Laboratory Automation & Robotics

Sai Life Sciences’ Biotech Pitch Day 2026 Spotlights Emerging Innovation and Forges Crucial Collaborations in the Drug Discovery Landscape

Lana Keisha Apr 16, 2026 0

Boston, MA – Sai Life Sciences, a leading global contract research, development, and manufacturing organization (CRDMO), recently convened its highly…

Read More

Posts pagination

1 2 3 4
Yale Researchers Identify Key Proteins That Drive the Spread of Parkinson’s Disease Throughout the Brain5 Key Concepts Behind Agentic AI Every Engineer Must UnderstandRemepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sEli Lilly’s Retatrutide Achieves Unprecedented Weight Loss in TRIUMPH-1 Trial, Signaling New Era in Obesity Pharmacotherapy
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ